• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

A Dose of Reality for OB: Oncology Wants You OUT!


<



















OB with his zero oncology experience is expecting us to follow his "oncology" lead! That’ll will happen when pigs fly and hell freezes over. No one respects OB in oncology.
 








Similar threads